Purpose: Currently, there is no consensus regarding the choice of anesthetic technique for parturients with sickle cell disease (SCD). The aim of the study was to determine the impact of the anesthetic technique on the occurrence of postnatal sickling complications.
Methods: We reviewed the charts of all pregnant women with SCD who had given birth in our institution between January 2002 and January 2007. Data related to pregnancy and anesthetic management and complications related, or unrelated, to SCD were recorded. Full blood count and lactate dehydrogenase values were recorded on the day of delivery. Risk factors for postnatal sickling complications were evaluated using a logistic regression analysis to estimate odds ratios (OR) and their 95% confidence intervals (95% CI).
Results: Fourteen of the 55 women (24%) experienced at least one postnatal sickling complication. Women who developed postnatal sickling complications were found to have a higher leukocyte count (17.0+/-6.1x10(9).L(-1) vs 12.8+/-4.4x10(9).L(-1), P=0.008) and a lower hemoglobin level (7.8+/-1.1 vs 8.9+/-1.0 g.dL(-1), P=0.002). General anesthesia (OR=16.0; 95% CI, 1.6 to 165.6) and a leukocyte count>or=15x10(9).L(-1) (OR=8.4; 95% CI, 1.6 to 44.5) were identified as risk factors. Neuraxial anesthesia and use of ephedrine were not identified as risk factors. There were no deaths.
Conclusion: Our study suggests that general anesthesia could be associated with postnatal sickling complications, even when the severity of illness was taken into account.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF03017204 | DOI Listing |
Rev Bras Enferm
December 2024
Universidade Estadual de Feira de Santana. Feira de Santana, Bahia, Brazil.
Objectives: to analyze principles of respectful maternity care in narratives of postpartum women with sickle cell disease, relating them to Sustainable Development Goals.
Methods: netnographic study, with two videos published in 2020. Deductive iconographic and thematic analysis by Respectful Maternity Care Charter, organized in MAXQDA.
AJOG Glob Rep
November 2024
Department of Family Medicine, Indiana University School of Medicine, Indianapolis, IN (Okuyemi).
Background: Sickle cell disease (SCD) has evolved from a condition predominantly fatal in childhood to a chronic illness impacting many adults, including women of reproductive age. For females with SCD, pregnancy represents one of the greatest health threats, exacerbating existing health challenges and introducing new risks. Despite advancements in healthcare, routine screening for existing complications like pulmonary hypertension (PH) remains inconsistent, particularly in low- and middle-income countries (LMICs), where the prevalence of SCD is highest.
View Article and Find Full Text PDFTransfus Med Rev
October 2024
Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States. Electronic address:
Int J Neonatal Screen
September 2024
Vanderbilt Institute for Global Health, Nashville, TN 37232, USA.
Hematol Transfus Cell Ther
November 2024
Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USA.
Introduction: The incidence of feto-maternal complications is high in women with sickle cell disease. The paucity of high-quality evidence has led to conditional recommendations for transfusional support in pregnant patients. This study aimed to assess if scheduled partial red cell exchanges impact pregnancy outcomes in sickle cell disease patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!